These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 16011036)
1. [Application of RNAi in gene-deficient models]. Tan YL; Yin QW Yi Chuan Xue Bao; 2005 Apr; 32(4):434-41. PubMed ID: 16011036 [TBL] [Abstract][Full Text] [Related]
2. Exploring in vitro roles of siRNA in cardiovascular disease. Tang Y; Ge YZ; Yin JQ Acta Pharmacol Sin; 2007 Jan; 28(1):1-9. PubMed ID: 17184576 [TBL] [Abstract][Full Text] [Related]
3. [RNA interference and its application in inhibiting HIV-1 infection]. Wei L; Liu X; Cao C Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):516-9. PubMed ID: 16176084 [TBL] [Abstract][Full Text] [Related]
4. RNA interference and its current application in mammals. Shen WG Chin Med J (Engl); 2004 Jul; 117(7):1084-91. PubMed ID: 15265387 [TBL] [Abstract][Full Text] [Related]
5. The silent treatment: siRNAs as small molecule drugs. Dykxhoorn DM; Palliser D; Lieberman J Gene Ther; 2006 Mar; 13(6):541-52. PubMed ID: 16397510 [TBL] [Abstract][Full Text] [Related]
6. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors. Sun Y; Li Z; Li L; Li J; Liu X; Li W Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648 [TBL] [Abstract][Full Text] [Related]
7. [Application of RNAi technology to knockdown gene expression in vivo in mammalians]. Zhang AH; Liu GQ Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):125-9. PubMed ID: 15285417 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic application of RNA interference for hepatitis C virus. Watanabe T; Umehara T; Kohara M Adv Drug Deliv Rev; 2007 Oct; 59(12):1263-76. PubMed ID: 17822803 [TBL] [Abstract][Full Text] [Related]
14. Application of RNAi to cancer research and therapy. Tan FL; Yin JQ Front Biosci; 2005 May; 10():1946-60. PubMed ID: 15769676 [TBL] [Abstract][Full Text] [Related]
15. Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype. Watanabe T; Sudoh M; Miyagishi M; Akashi H; Arai M; Inoue K; Taira K; Yoshiba M; Kohara M Gene Ther; 2006 Jun; 13(11):883-92. PubMed ID: 16496015 [TBL] [Abstract][Full Text] [Related]
16. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells. Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668 [TBL] [Abstract][Full Text] [Related]